Patent Yard Sign in
Canadian application, no grantCanada

Targeted vaccine delivery systems

CA 2406378 A1 · Owner: Zauderer, Maurice · Inventors: Smith, Ernest S.; Zauderer, Maurice

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

The present invention is directed to a novel targeted vaccine delivery system comprising one or more MHC-peptide complexes linked to an antibody which is specific for a cell surface marker. The complexes of the invention are useful for treating and/or preventing cancer, infectious diseases autoimmune , diseases, and/or allergies.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed April 12, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended April 12, 2021.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by April 12, 2023.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledApril 12, 2001
GrantedNo grant recorded
Term endedApril 12, 2021
Patent numberCA 2406378 A1
Classification (IPC)C12N15/62 +2 more

Timeline

Timeline From CIPO dates

2002200420062008201020122014201620182020Application filedApril 12, 2001Term endedApril 12, 2021

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.